Display options
Cite
Ribeiro RC, Antillon F, Pedrosa F, et al. Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries. J Clin Oncol. 2015;34(1):53-61doi: 10.1200/JCO.2015.61.9148.
Ribeiro, R. C., Antillon, F., Pedrosa, F., & Pui, C. H. (2016). Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(1), 53-61. https://doi.org/10.1200/JCO.2015.61.9148
Ribeiro, Raul C, et al. "Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34,1 (2016): 53-61. doi: https://doi.org/10.1200/JCO.2015.61.9148
Ribeiro RC, Antillon F, Pedrosa F, Pui CH. Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries. J Clin Oncol. 2016 Jan 01;34(1):53-61. doi: 10.1200/JCO.2015.61.9148. Epub 2015 Nov 17. PMID: 26578620; PMCID: PMC4980571.
Copy Download .nbib Format: NLM
Share it on

J Clin Oncol. 2016 Jan 01;34(1):53-61. doi: 10.1200/JCO.2015.61.9148. Epub 2015 Nov 17.

Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Raul C Ribeiro, Federico Antillon, Francisco Pedrosa, Ching-Hon Pui

Affiliations

  1. Raul C. Ribeiro and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Federico Antillon, Unidad Nacional de Oncologia Pediatrica and Universidad Francisco Marroquin, Guatemala City, Guatemala; and Francisco Pedrosa, Instituto de Medicina Integral Fernando Figueira, Recife, Brazil. [email protected].
  2. Raul C. Ribeiro and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Federico Antillon, Unidad Nacional de Oncologia Pediatrica and Universidad Francisco Marroquin, Guatemala City, Guatemala; and Francisco Pedrosa, Instituto de Medicina Integral Fernando Figueira, Recife, Brazil.

PMID: 26578620 PMCID: PMC4980571 DOI: 10.1200/JCO.2015.61.9148

Abstract

Partnerships between medical institutions in high-income countries (HICs) and low- to mid-income countries (LMICs) have succeeded in initiating and expanding pediatric cancer control efforts. The long-term goal is consistently a sustainable national pediatric cancer program. Here, we review the elements required for successful implementation, development, and long-term sustainability of pediatric cancer programs in LMICs that first arise as partnerships with institutions in HICs. Although plans must be adapted to each country's resources, certain components are unfailingly necessary. First, an essential step is provision of treatment regardless of ability to pay. Second, financial support for program development and long-term sustainability must be sought from sources both international and local, public and private. A local leader, typically a well-trained pediatric oncologist who devotes full-time effort to the project, should direct medical care and collaborate with hospital, governmental, and community leadership and international agencies. Third, nurses must be trained in pediatric cancer care and allowed to practice this specialty full-time. It is also essential to develop a grassroots organization, such as a foundation, dedicated solely to pediatric oncology. Its members must be trained and educated to provide pediatric cancer advocacy, fundraising, and (in concert with government) program sustainability. Finally, a project mentor in the HIC is crucial and should explore the possibility of collaborative research in the LMIC, which may offer significant opportunities. Relationships between the partnership's leaders and influential individuals in the community, hospital, grassroots foundation, and government will lay the foundation for productive collaboration and a sustainable pediatric oncology program.

© 2015 by American Society of Clinical Oncology.

References

  1. JAMA. 2004 May 26;291(20):2471-5 - PubMed
  2. Eur J Cancer. 2008 Nov;44(16):2388-96 - PubMed
  3. Lancet Oncol. 2008 Aug;9(8):721-9 - PubMed
  4. J Pediatr (Rio J). 2007 Nov-Dec;83(6):547-54 - PubMed
  5. Pediatr Blood Cancer. 2014 May;61(5):827-32 - PubMed
  6. PLoS Med. 2014 Jun 17;11(6):e1001656 - PubMed
  7. Pediatr Blood Cancer. 2007 Aug;49(2):139-44 - PubMed
  8. Cancer. 2008 Feb 1;112(3):461-72 - PubMed
  9. Pediatr Blood Cancer. 2013 May;60(5):810-5 - PubMed
  10. Asian Pac J Cancer Prev. 2012;13(12):6491-6 - PubMed
  11. Pediatr Blood Cancer. 2009 Oct;53(4):557-62 - PubMed
  12. Lancet Oncol. 2013 Mar;14(3):e104-16 - PubMed
  13. Expert Rev Hematol. 2014 Oct;7(5):649-57 - PubMed
  14. Pediatr Blood Cancer. 2012 Feb;58(2):163-6 - PubMed
  15. Pediatr Blood Cancer. 2007 Apr;48(4):486-90 - PubMed
  16. Pediatr Blood Cancer. 2014 Nov;61(11):2071-3 - PubMed
  17. Pediatr Blood Cancer. 2014 Feb;61(2):345-54 - PubMed
  18. Leukemia. 2005 Mar;19(3):323-5 - PubMed
  19. Eur J Cancer. 2013 Jul;49(11):2555-64 - PubMed
  20. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):784-92 - PubMed
  21. Leukemia. 2000 Feb;14(2):336-7 - PubMed
  22. J Pediatr Hematol Oncol. 2015 Apr;37(3):181-4 - PubMed
  23. N Engl J Med. 2014 Feb 6;370(6):552-7 - PubMed
  24. Curr Opin Pediatr. 2013 Feb;25(1):3-15 - PubMed
  25. Int J Pediatr. 2012;2012:129707 - PubMed
  26. Maturitas. 2013 Sep;76(1):95-8 - PubMed

MeSH terms

Publication Types

Grant support